Cerebral Microbleeds Associate with Brain Endothelial Cell Activation-Dysfunction and Blood-Brain Barrier Dysfunction/Disruption with Increased Risk of Hemorrhagic and Ischemic Stroke.
Level 5 - mechanism / opinion, no new human data
Narrative review of mechanisms and clinical associations without primary empirical data or systematic review methodology.
PubMed 39062035 · doi:10.3390/biomedicines12071463
What was done
This narrative review synthesized literature on cerebral microbleeds (CMBs), focusing on their neuroimaging features (3–5 mm hypointense lesions on T2*-weighted gradient recall echo or susceptibility-weighted MRI), underlying mechanisms involving brain endothelial activation and blood-brain barrier disruption, and associations with cerebral small vessel disease.
What was found
The abstract reports no primary quantitative data, statistical comparisons, or effect sizes. It describes qualitatively that CMBs are prevalent in older adults and notes that a burden of ≥10 CMBs represents an increased risk for large symptomatic intracerebral hemorrhages, while also serving as markers for ischemic stroke and neurodegenerative decline.
Why it matters
It highlights cerebral microbleeds as accessible neuroimaging markers linking microvascular barrier failure to broader risks of hemorrhagic stroke, ischemic stroke, and cognitive impairment in aging populations.
Limits
As a narrative review, it presents no primary clinical data, quantitative meta-analytic pooling, or formal study inclusion criteria. Specific effect estimates, risk ratios, and confounding factors are not reported in the abstract.
Cited by
- supports Alzheimer's disease and small vessel disease both exhibit microbleeds on brain MRI caused by blood-brain barrier breakdown allowing red blood cells into the brain.